72 filings
10-Q
2024 Q1
COYA
Coya Therapeutics Inc
Quarterly report
9 May 24
4:26pm
8-K
COYA
Coya Therapeutics Inc
9 May 24
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
4:20pm
8-K
COYA
Coya Therapeutics Inc
8 May 24
Departure of Directors or Certain Officers
5:21pm
ARS
2023 FY
COYA
Coya Therapeutics Inc
28 Mar 24
Annual report to shareholders
4:40pm
DEFA14A
COYA
Coya Therapeutics Inc
28 Mar 24
Additional proxy soliciting materials
4:35pm
8-K
uiu02hk
19 Mar 24
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results
8:21am
8-K
xxbwn13 bgm
19 Jan 24
Other Events
8:15am
424B3
0zhesrtyl2
16 Jan 24
Prospectus supplement
4:06pm
EFFECT
dcwim8m pz31azcv
16 Jan 24
Notice of effectiveness
12:15am
CORRESP
ljwn8sf
10 Jan 24
Correspondence with SEC
12:00am
UPLOAD
0w6n70 v9gd
9 Jan 24
Letter from SEC
12:00am
S-3
ckrg49
4 Jan 24
Shelf registration
4:46pm
D
vaw tpkw7ra
20 Dec 23
$26.48 mm in equity / options / securities to be acquired, sold $26.48 mm, 122 investors
9:46am
8-K
7bl155pg1oq
20 Dec 23
Departure of Directors or Certain Officers
8:35am
8-K
h050orksc uu3sj8raia
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
9mb3v ig3q5o
8 Nov 23
Coya Therapeutics, Inc. Provides Business Update and Reports Q3 2023 Unaudited Financial Results
9:03am
8-K
sib 5k13irx
21 Aug 23
Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, joins Coya’s Board of Directors
5:01pm